Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-24-023233

Chief Executive Officer sold 5,000 shares at $10.65 ($53,274)

  • Chief Executive Officer acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Townsend Richard Nolan · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-10 Exercise or conversion : show line 1 in the form 10b5-1 +5,000 $2.33 $11,650 125,695 D
2024-09-10 Sale : show line 2 in the form 10b5-1 −5,000 $10.65 $53,274 120,695 D
Open-market sales · 5,000 sh · avg $10.65 · $53,274

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-10 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −5,000 128,655 D
Loading xslF345X05/form4-09112024_090900.xml…